Clinical Trial Update: Effects of PR Oxycodone and of Levodopa, vs Placebo, on Central Neuropathic Pain in Parkinson's Disease [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating the effects of PR oxycodone and levodopa versus placebo on central neuropathic pain in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• PR oxycodone (oxycodone)
• levodopa (levodopa)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Parkinson Disease | Phase 2, Phase 3 | Status: COMPLETED